Miravo Healthcare to launch Blexten in Canada

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Ontario, Canada (CU)_ Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare, a Canada-based healthcare firm with global footprint and a diverse portfolio of commercial medicines, revealed the introduction of Blexten by its wholly owned branch, Aralez Pharmaceuticals Canada Inc. for pediatric patients aged 4 years and older.

Jesse Ledger, President & Chief Executive Officer of Miravo, expressed delight over the launch. He said, “Our sales force is excited to present our new Blexten formulations to the healthcare community. Blexten pediatric was approved by Health Canada in mid August 2021. The recent Canadian launch of the two new formats of Blexten, 10mg tablet and 2.5mg/mL oral solution for pediatric use, in addition to our existing 20mg tablet format available for patients 12 years of age and older, provides a single prescription antihistamine option for most Canadian allergy and urticaria patients”.

Timothy Vander Leek, MD, FRCPC, Clinical Immunologist & Allergist in Pediatrics Department at the Stollery Children’s Hospital in University of Alberta, expressed hopes over medicine. He said, “The introduction of Blexten pediatric with two new formats, orodispersible tablet (quick melt) and oral solution, gives us new prescription antihistamine options for allergy symptom control in children.”

aplususapharma

Dr. Jaggi Rao, MD, FRCPC (Dermatology) and Professor of Dermatology and Clinical Medicine at University of Alberta, expressed optimism over the launch of the new medicine. He said, “A new prescription strength antihistamine for children 4 years of age and over is a welcome addition to our treatment options for the hives and itching of chronic spontaneous urticaria.”

Blexten is a second-generation antihistamine medication used to treat allergic rhinitis and chronic spontaneous urticaria. Blexten works by inhibiting peripheral histamine H1 receptors with an effectiveness equivalent to cetirizine and desloratadine. Miravo is a Canadian-based healthcare firm with a global footprint and a diverse commercial product range. The company’s medicines are used to treat a variety of medical conditions, such as pain, allergies, neurology, and dermatology.

A Personal Note from the Publisher" Small photo of you, with your signature beneath

A Personal Note from the Publisher

My dear friend, thank you for your time with us today. This site was built for you, the members of the Commonwealth Family, and nothing matters more to me than hearing your voice and feedback.

What did you make of this article? Did it inform you, challenge you, or leave you wanting more?

Please tell me. I read your replies personally and they help shape everything we publish.

With warmest wishes,
Hon. Nirj Deva
Founder and Publisher.

Free, always. We'll never sell your details.

Hot this week

Sri Lanka Storms into Tri-Series Final with Dominant Win over Pakistan

White-ball cricket is often lauded internationally for its high-scoring...

The Commonwealth and the Question of Reparatory Justice

The legacy of the transatlantic slave trade and calls...

Australia’s Education Empire Under Threat: Why Are International Students Suddenly Favouring the UK and the US?

SYDNEY, AUSTRALIA — 30 OCTOBER 2026 For many years, Australia...

Under the Greenwood Tree: Can Love Survive When Tradition Fades and Ambition Takes Root?

Thomas Hardy’s Under the Greenwood Tree, published anonymously in...
- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories